SOM Biotech

Drug Repurposing Company focused on neurological rare diseases.

Total raised

€7.0M

€7,000,000

Funding rounds

Investors

distinct backers

Active since

2018-12

latest 2018-12

Funding by year

EUR raised per year

Medium confidence

Raise-next likelihood18

base rate 44% for Series A

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

1 rounds

Date	Stage	Amount	Investors
2019-01-01	Series A	€7.0M	—	View deal →

same sector or country